VRSPi: towards a neuroadaptive VR exposure therapy system for spider phobia

Area of Science:

• Neuroscience
• Psychiatry
• Virtual Reality Technology

Background:

• Arachnophobia is a prevalent phobia causing significant distress.
• Virtual Reality-based Exposure Therapy (VRET) shows promise for treating phobias.
• Personalized treatment approaches are needed to enhance VRET efficacy.

Purpose of the Study:

• To develop and test a proof-of-concept neuroadaptive and individualized VRET system (VRSpi) for arachnophobia.
• To integrate real-time neurophysiological monitoring (EEG and HR) for personalized fear stimulus control.
• To assess the feasibility of using frontal alpha asymmetry (FAA) for adaptive fear level assessment.

Main Methods:

• Twenty-one participants with moderate spider fear were exposed to VR spider stimuli.
• Frontal electroencephalography (EEG) for frontal alpha asymmetry (FAA) and heart rate (HR) were monitored in real-time.
• The VRSpi system used FAA and HR to automatically adjust the intensity of VR fear stimuli.

Main Results:

• The system demonstrated that incorporating FAA measurements can personalize VRET by adapting to individual fear levels.
• Escalating VR spider exposure correlated with changes in brain activity (reduced faster band power, increased theta activity) and HR.
• Distinct neurophysiological patterns reliably differentiated between low and high fear states during VR exposure.

Conclusions:

• Neuroadaptive VRET systems integrating real-time neurophysiological data show potential for personalized arachnophobia treatment.
• FAA and HR monitoring can provide objective measures for adapting VRET intensity.
• Further research is needed to validate clinical outcomes and address practical integration challenges for widespread therapeutic use.